StockData
Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc. (EWTX) stock

EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$42.04−1.64 (-3.75%)

Close on Nov 17, 2026Market cap $4.57BP/E –Yield –

Edgewise Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Edgewise Therapeutics's price to book ratio was 11.4× on Nov 11, 2026, against 4.9× a year earlier. Over the last 5 years it ranged from 1.2× to 11.4×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.4×+6.7
2025Dec 31, 20254.7×−0.5
2024Dec 31, 20245.2×+2.8
2023Dec 29, 20232.4×+0.8
2022Dec 30, 20221.6×−1.1
2021Dec 31, 20212.6×–

More Edgewise Therapeutics figures

See a number that looks wrong?